Physician profile
Larry M Neuman
NPI 1992907539
$456,977.30
in general payments reported to CMS, 2019-2025
75 companies · $116K in 2025
The $116K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52K · 2020: $53K · 2021: $42K · 2022: $60K · 2023: $71K · 2024: $63K · 2025: $116K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $137K · Honoraria: $44K · Consulting Fee: $30K · Food and Beverage: $30K · Travel and Lodging: $10K · Education: $91.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $136,611.25 |
| Honoraria | $43,887.50 |
| Consulting Fee | $29,779.50 |
| Food and Beverage | $29,763.50 |
| Travel and Lodging | $10,093.62 |
| Education | $91.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $164,026.92 | 2019-2025 | |
| Axsome Therapeutics, INC. | $61,913.05 | 2023-2025 | Auvelity, Symbravo |
| Allergan, INC. | $52,428.81 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $47,988.99 | 2021-2025 | Caplyta |
| Gilead Sciences, INC. | $33,709.43 | 2019-2024 | Descovy |
| Cmp Pharma, INC. | $27,015.23 | 2021-2024 | Atorvaliq, Carospir, Norliqva |
| Sumitomo Pharma America, INC. | $14,567.11 | 2023-2025 | Gemtesa, Myfembree |
| Intra-Sana Laboratories | $9,395.77 | 2023-2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $8,875.29 | 2019-2025 | Xifaxan, Trulance, Relistor |
| Esperion Therapeutics, INC. | $6,338.50 | 2021-2025 | Nexletol, Nexlizet |
| Astrazeneca Pharmaceuticals Lp | $4,895.32 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Agepha Pharma Fz LLC | $2,562.40 | 2024-2025 | Lodoco |
| Biohaven Pharmaceuticals, INC. | $2,220.13 | 2021 | |
| Glaxosmithkline, LLC. | $1,436.50 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Sunovion Pharmaceuticals INC. | $1,341.55 | 2020-2021 |
Show all 75 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $1,030.39 | 2024-2025 | Ibsrela |
| Amgen INC. | $1,012.81 | 2019-2025 | Otezla, Repatha, Repatha |
| Urovant Sciences INC | $889.99 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $828.37 | 2019-2021 | |
| Novo Nordisk INC | $821.14 | 2019-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $764.18 | 2020-2025 | |
| Lilly USA, LLC | $734.33 | 2019-2025 | Mounjaro, Zepbound, Emgality |
| Janssen Pharmaceuticals, INC | $656.29 | 2019-2023 | Xarelto |
| Janssen Products, Lp | $653.90 | 2019-2023 | Symtuza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $563.60 | 2019-2021 | |
| Phathom Pharmaceuticals, INC. | $538.10 | 2025 | Voquezna |
| Janssen Biotech, INC. | $508.69 | 2019-2023 | Symtuza |
| Biohaven Pharmaceutical Holding Company Ltd. | $507.02 | 2022 | |
| Xeris Pharmaceuticals, INC. | $489.46 | 2023-2025 | Recorlev, Keveyis |
| Exact Sciences Corporation | $458.69 | 2023-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $443.70 | 2019-2021 | |
| Biocryst US Sales Co., LLC | $417.80 | 2021-2023 | Orladeyo |
| Otsuka America Pharmaceutical, INC. | $392.64 | 2019-2025 | Rexulti |
| Alkermes, INC. | $372.43 | 2022-2023 | Aristada, Lybalvi |
| Mannkind Corporation | $372.02 | 2019-2023 | Afrezza |
| Vanda Pharmaceuticals INC. | $352.07 | 2025 | Fanapt |
| Bayer Healthcare Pharmaceuticals INC. | $345.62 | 2021-2024 | |
| Avanir Pharmaceuticals, INC. | $291.79 | 2019 | |
| Viiv Healthcare Company | $280.08 | 2024-2025 | Apretude, Dovato |
| Teva Pharmaceuticals USA, INC. | $275.40 | 2024-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Genentech USA, INC. | $272.68 | 2020-2021 | |
| Intuity Medical INC | $268.13 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Horizon Therapeutics Plc | $244.51 | 2021-2022 | |
| Corcept Therapeutics | $240.11 | 2023-2025 | Korlym |
| Nestle Healthcare Nutrition INC. | $233.67 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $215.98 | 2023-2024 | Quviviq |
| Merck Sharp & Dohme LLC | $205.33 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $199.99 | 2024-2025 | Nuzyra |
| Mylan Specialty L.P. | $190.36 | 2019-2023 | Yupelri |
| Novartis Pharmaceuticals Corporation | $186.98 | 2021-2024 | |
| Beta Bionics, INC. | $177.15 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Cequr Corporation | $163.75 | 2024 | Cequr Simplicity |
| Scilex Pharmaceuticals INC. | $150.19 | 2021-2023 | Ztlido |
| Scpharmaceuticals INC. | $139.65 | 2024 | |
| Ucb, INC. | $124.50 | 2019 | |
| Janssen Scientific Affairs, LLC | $121.54 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.14 | 2021 | |
| Astellas Pharma US INC | $111.01 | 2020-2022 | |
| Biogen, INC. | $110.31 | 2020-2021 | |
| Lundbeck LLC | $108.09 | 2023-2024 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $99.67 | 2022-2025 | Zoryve |
| Abbott Laboratories | $98.49 | 2025 | Freestyle Libre 3 |
| Aimmune Therapeutics, INC. | $84.59 | 2024-2025 | Zenpep |
| Azurity Pharmaceuticals, INC. | $79.45 | 2024 | Edarbi |
| Ironwood Pharmaceuticals, INC | $73.11 | 2019-2025 | Linzess |
| Cipher Pharmaceuticals US LLC | $68.02 | 2025 | Spinosad, Natroba |
| E.R. Squibb & Sons, L.L.C. | $34.66 | 2021 | |
| Dexcom, INC. | $30.65 | 2024 | Dexcom G6 Transmitter |
| Incyte Corporation | $20.32 | 2025 | Opzelura |
| Biocryst Pharmaceuticals, INC. | $17.62 | 2020 | |
| Mission Pharmacal Company | $16.84 | 2019 | |
| Optinose US, INC. | $16.02 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.15 | 2020 | |
| Ibsa Pharma INC. | $15.11 | 2023 | Tirosint, Licart |
| Regeneron Healthcare Solutions, INC. | $14.02 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Neuman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.